
You can purchase shares of BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (OTCPK:BPMUF) through any online brokerage.
There are no as such competitors for BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG.
There is no analysis for BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG to provide a consensus price target.
The stock price for BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG (OTCPK: BPMUF) is $84 last updated November 11, 2026 at 1:15 PM EST.
There are no upcoming dividends for BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG.
BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG does not have any upcoming earnings scheduled.
There is no upcoming split for BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG.
BASILEA PHARM AG AKT SHS by Basilea Pharmaceutica AG is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries...